Hypoplastic Left Heart Syndrome
47
3
5
28
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.8%
6 terminated out of 47 trials
82.4%
-4.2% vs benchmark
2%
1 trials in Phase 3/4
36%
10 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (47)
Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
Effect of Fetal Aortic Valvuloplasty on Outcomes
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)
Cerebral Anatomy, Hemodynamics and Metabolism
Hypoplastic Left Heart Syndrome: Subendocardial Viability After Norwood Palliation
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
Maternal Hyperoxygenation in Congenital Heart Disease
Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)
Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome